| 000 | 00903 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250517012210.0 | ||
| 264 | 0 | _c20160202 | |
| 008 | 201602s 0 0 chi d | ||
| 022 | _a0513-4870 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhao, Shuang-shuang | |
| 245 | 0 | 0 |
_a[Potential targets for anti-liver fibrosis]. _h[electronic resource] |
| 260 |
_bYao xue xue bao = Acta pharmaceutica Sinica _cOct 2014 |
||
| 300 |
_a1365-71 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aCollagen _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntegrin alphaV _xmetabolism |
| 650 | 0 | 4 |
_aLiver _xpathology |
| 650 | 0 | 4 |
_aLiver Cirrhosis _xdrug therapy |
| 650 | 0 | 4 |
_aTransforming Growth Factor beta1 _xmetabolism |
| 700 | 1 | _aShao, Rong-guang | |
| 700 | 1 | _aHe, Hong-wei | |
| 773 | 0 |
_tYao xue xue bao = Acta pharmaceutica Sinica _gvol. 49 _gno. 10 _gp. 1365-71 |
|
| 999 |
_c24524150 _d24524150 |
||